Navigation Links
Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Date:8/20/2007

CARLSBAD, Calif., Aug. 17 /PRNewswire/ -- AutoGenomics, a leader in developing automated molecular testing solutions, announced today that its CYP450 2C9-VKORC1 panel that it submitted to the FDA for 510(k) clearance late last year, has now been evaluated by the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics (HPCGG).

Warfarin (also called Coumadin) is a drug prescribed to help prevent blood clots. With more than 2 million prescriptions per year, one of the side effects of the drug is an increased risk of bleeding. The FDA re-labeled yesterday the warfarin package insert recommending the testing of multiple genetic variants in two genes namely 2C9 and VKORC1 for safer drug dosing.

"We have completed a successful evaluation of the INFINITI 2C9-VKORC1 panel which has the potential to optimize warfarin dosing and lower the risk of bleeding complications" said Dr. Raju Kucherlapati, Scientific Director of the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics (HPCGG) in Cambridge, Massachusetts. HPCGG is coordinating the "CReating an Optimal Warfarin Nomogram" (CROWN) Trial which is a prospective dosing study utilizing genetic testing to determine the optimal warfarin dose and how this information can be used for clinical care.

"We are pleased to see that through the re-labeling of the warfarin package insert, the FDA has recognized that patients with certain genetic variants may benefit from lower initial dosage thus reducing the risk of major bleeding events" said Ram Vairavan, Senior Vice President at AutoGenomics. He further said "Our expanded panel of genetic variants mentioned in the package insert encompassing African, Asian and other ethnic groups enables same day dosing on our automated multiplexing platform."

About AutoGenomics

AutoGenomics Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic pla
'/>"/>

SOURCE AutoGenomics Inc

Copyright©2007 PR Newswire.

Page: 1 2

Related medicine technology :

1. Antidepressant Use May Boost Fracture Risk, From Harvard Womens Health Watch
2. Bipolar Disorder in Children Difficult to Diagnose, Reports the Harvard Mental Health Letter
3. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
4. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
5. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
6. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
7. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
8. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
9. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
10. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
11. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ... directors of Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... breached its fiduciary duties to shareholders. On ... investing website reporting that Advaxis had misrepresented the clinical ...
(Date:1/23/2015)... Inc., a leader in hand hygiene monitoring, today announced ... subsidiary of Ascendis Health Limited, in Johannesburg, ... of millions of patients around the world are affected ... patient to patient via the unwashed hands of healthcare ...
(Date:1/23/2015)... Companies, Inc. (ICBU) has repositioned itself as a holding company ... foothold in the hydroponic, hemp and medical marijuana sectors. By ... the sector, and recently partnering with the Chippewa Tribe Nation ... marijuana, iMD is committing to bring its vision to the ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... The AquaLab Vapor Sorption Analyzer (VSA) , ... understand moisture in products and pinpoint quality control issues.  ... humidity changes can reveal important details about physical and ... is called an isotherm.  Isotherm generation ...
... Jan. 10, 2012 Heraeus Kulzer, LLC, the worldwide leader ... seminars at the Chicago Dental Society Midwinter Meeting ... A Class IV Workshop: Great Cosmetic Results With Nanotechnology ... noon. Speakers: Frank Milnar, DDS and Shannon Pace-Brinker, CDA ...
Cached Medicine Technology:New AquaLab Vapor Sorption Analyzer Puts Isotherm Technology Within Financial Reach of Food and Pharmaceutical Scientists 2Heraeus to Sponsor Four Seminars at Chicago Dental Society Midwinter Meeting 2012 2Heraeus to Sponsor Four Seminars at Chicago Dental Society Midwinter Meeting 2012 3
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue ... means to “Live Fearless.” , The “Faces of ... stories about how they or someone they know has faced ... in the moment. By telling these types of stories through ...
(Date:1/22/2015)... January 22, 2015 The federal court overseeing ... U.S. District Court, Southern District of West Virginia has upheld ... that proceeding’s first bellwether trial. In an Order dated January ... trial after finding that C.R. Bard had not proven a ...
(Date:1/22/2015)... 2015 A new white paper by ... person-centeredness in the long-term care environment as well as ... continuum. The paper, “The Power of Person-Centeredness in Long-Term ... practices of the patient, resident and family experience in ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post ... insurance policy . , Auto insurance quotes help many ... no longer necessary to call an agent or visit an ... on a single website: http://autocarinsurancebest.com/ . , Every business ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... Thermage, Inc.,(Nasdaq: THRM ), announced today that ... and full year ended December 31, 2007, after the,market ... also host a,conference call and webcast on Tuesday, February ... to discuss the financial results and,current corporate developments. The ...
... The Bishop of Manchester,has made a series of serious ... researcher, inventor of the science of,Plastination, and creator of ... and at a Press Conference at Manchester Cathedral on ... WORLDS 4,exhibition, to be hosted by the Museum of ...
... It,s one thing to daydream about all,the free time ... to,seriously map out the steps you need to take ... Listen to this report from AXA Equitable (NYSE: ... access video, audio, text, graphics and,photos for free and ...
... study, a new technique helped patients retrieve long-lost details ... interviewing technique has drawn out extensive details hidden in ... researchers say. , There,s ongoing debate about whether long-term ... the medial temporal lobe, which contains the memory-processing center ...
... Record Annual Net Sales and Net Income, SALT LAKE ... a leading producer of advanced digital hearing aids,today announced results ... 2007 of $32.3 million were up 12.4% over the $28.7 ... year 2007 of $122.5,million improved 16.1% over the $105.5 million ...
... of $55.9 Million and Contract Value ... Growth of ... WASHINGTON, Feb. 5 The Advisory Board Company,(Nasdaq: ABCO ) ... March 31, 2008. Revenue for the quarter increased,15% to $55.9 million, from ...
Cached Medicine News:Health News:The Institute for Plastination Responds to the Bishop of Manchester's Media Blitz, Assertions, and Allegations About BODY WORLDS Anatomical Exhibition Coming to Manchester 2Health News:The Institute for Plastination Responds to the Bishop of Manchester's Media Blitz, Assertions, and Allegations About BODY WORLDS Anatomical Exhibition Coming to Manchester 3Health News:The Institute for Plastination Responds to the Bishop of Manchester's Media Blitz, Assertions, and Allegations About BODY WORLDS Anatomical Exhibition Coming to Manchester 4Health News:Brain Injury May Not Erase Long-Term Memory 2Health News:Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007 2Health News:Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007 3Health News:Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007 4Health News:Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007 5Health News:Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007 6Health News:Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007 7Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 2Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 3Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 4Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 5Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 6Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 7Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 8Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 9Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 10Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 11Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 12Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 13Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 14Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 15
Caspar cervical retractor (lamina spreader), counter-retractor complete with 5 blades and forceps. Height: max. 165 mm, Maximal spread: 85 mm...
Cervical retractor with post....
Small, removable blades, length 178 mm, (7"). Function: tissue retracting....
Toothed Pituitary IVD Rongeurs, 8 length 200 mm....
Medicine Products: